Watch out for these unapproved cough and cold meds - - Modern Medicine
Watch out for these unapproved cough and cold meds

The Food and Drug Administration (FDA) has succeeded in getting an injunction from a federal court against a company manufacturing unapproved cough and cold medications.

The injunction bars contract manufacturer Neilgen Pharmaceuticals (Westminster, Md) and its parent company Advent Pahrmaceuticals (East Windsor, N.J.) from distributing any of its unapproved medical products. Neilgen may also be known as Unigen Pharmaceuticals. The company does private-label store brand manufacturing for supermarkets and drug stores, so many of its products may be under multiple labels.

FDA released a partial list of Neilgen’s products: RE All 12 suspension, BP Allergy Junior suspension, PE Tann 20 mg/CP Tann 4 mg suspension, BP New Allergy DM suspension, D-Tann CT tablets, B-Vex D suspension, Histex SR, and Chlorpheniramine Maleate 12 mg/Pseudoephedrine HCl 120 mg LA tablets.

Advent has been instructed to destroy any unapproved drugs. Pharmacists are not to dispense any of them, FDA said, and consumers should throw away any they have in their house.

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.

eSamples check closet
eSamples check closet
Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Formulary Counselor
Formulary Counselor

Find health plan drug coverage in your area. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here




Click here